BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 Pharmaceutical Technology Excellence Awards.

By analyzing over 213,000 developing human brain cells, researchers show that many autism risk genes act through the ECM.

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Last year’s chemistry Nobel prize was awarded to researchers using AI to study proteins in entirely new ways, and in 2025 ...

Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...

Rapid advances in sequencing technologies have transformed our ability to diagnose human genetic disorders, yet many patients still lack a molecular ...

In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...

Triglia discusses her research at the intersection of genetics, epigenetics, single-cell genomics and computational biology.

Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of ...